Nuevocor is a biotech start-up in Singapore focused on developing gene therapies for genetic cardiomyopathies by leveraging advanced cell biology and cutting-edge technology platforms, including novel gene therapy vectors and proteomics-based target discovery.
Headquarters:
Singapore
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2021 (4 years)
Address:
SINGAPORE, SG
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
HIGH
spending power
